Samsung Biologics Says PolyPeptide Tender Offer Draws 97.98% Stake
Bitget2026/11/05 23:47- Samsung Biologics disclosed in a Nov. 6, 2026 correction that its PolyPeptide Group tender offer secured 97.98%, representing 32,350,302 shares.
- The company plans to reach 100% ownership through measures including a compulsory acquisition of remaining minority stakes under Swiss law.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Microsoft Beats Nvidia for the First Time Since 2025: So Why Is MSFT Stock Falling?
Gunnison hits rich copper and zinc in Arizona
EIA expects Brent crude spot prices to remain at $100 per barrel for the rest of the year and raises the average price forecasts for this year and next.
The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.
Crypto prices
More
